Work

Phase II evaluation of tremelimumab (Treme) combined with high-dose interferon alpha-2b (HDI) for metastatic melanoma.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.8524

Authors: A. A. Tarhini, S. J. Moschos, H. Tawbi, Y. Shuai, W. E. Gooding, C. Sander, J. M. Kirkwood

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2269875167

Cites:

Cited by: 17

Related to: 10